Remus Pharmaceuticals

1,903.60
-52.75
(-2.70%)
Market Cap
1,121.60 Cr
EPS
152.01
PE Ratio
56.67
Dividend Yield
0.05 %
Industry
0.00
52 Week High
8,747.00
52 Week Low
1,785.10
PB Ratio
13.27
Debt to Equity
0.13
Sector
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
44.17 %
Net Income Growth
97.81 %
Cash Flow Change
690.16 %
ROE
-53.87 %
ROCE
-2.48 %
EBITDA Margin (Avg.)
35.81 %

Yearly Financial Results

Annual Financials
2024
TTM
Revenue
218
0
Expenses
185
0
EBITDA
33
0
Operating Profit %
13 %
0 %
Depreciation
1
0
Interest
1
0
Profit Before Tax
32
0
Tax
6
0
Net Profit
26
0
EPS in ₹
152.01
0.00

Balance Sheet

Balance Sheet
2024
Total Assets
257
Fixed Assets
12
Current Assets
210
Capital Work in Progress
0
Investments
3
Other Assets
243
Total Liabilities
257
Current Liabilities
150
Non Current Liabilities
4
Total Equity
104
Reserve & Surplus
85
Share Capital
2

Cash Flow

Cash Flow
2024
Net Cash Flow
19
Investing Activities
-9
Operating Activities
4
Financing Activities
24

Share Holding

% Holding
Mar 2023
May 2023
Sept 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
92.82 %
68.37 %
69.61 %
70.60 %
70.66 %
70.84 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.92 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.44 %
16.69 %
21.15 %
20.54 %
20.90 %
20.49 %
Others
0.74 %
14.02 %
9.24 %
8.85 %
8.44 %
8.67 %
No of Share Holders
30
1,743
856
1,124
1,577
1,753

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00

Corporate Action

Technical Indicators

RSI(14)
Neutral
35.72
ATR(14)
Less Volatile
79.04
STOCH(9,6)
Oversold
14.37
STOCH RSI(14)
Oversold
2.03
MACD(12,26)
Bearish
-20.33
ADX(14)
Weak Trend
15.65
UO(9)
Bearish
33.01
ROC(12)
Downtrend And Accelerating
-11.72
WillR(14)
Oversold
-93.74